Financhill
Back

Raia Drogasil SA Quote, Financials, Valuation and Earnings

Raia Drogasil SA Price Quote

$5.00

Raia Drogasil SA Key Stats

Sell
35
Raia Drogasil SA (RADLY) is a Sell

Day range:
$5.00 - $5.00
52-week range:
$4.11 - $8.25
Dividend yield:
1.05%
P/E ratio:
40.10
P/S ratio:
1.25
P/B ratio:
6.98%

Volume:
100
Avg. volume:
444
1-year change:
22.64%
Market cap:
$8.6B
Revenue:
$6.8B
EPS:
$0.12

How Much Does Raia Drogasil SA Make?

Is Raia Drogasil SA Growing As A Company?

  • What Is Raia Drogasil SA's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.21%
  • What Is Raia Drogasil SA's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.07%

Raia Drogasil SA Stock Price Performance

What Is Raia Drogasil SA 52-Week High & Low?

Raia Drogasil SA Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Raia Drogasil SA?

  • How Much Debt Does Raia Drogasil SA Have?
    Total long term debt quarterly is $645.1M
  • How Much Cash Does Raia Drogasil SA Have?
    Cash and short term investments quarterly total is $85M
  • What Is Raia Drogasil SA’s Book Value Per Share?
    Book value per share is 0.72

Is Raia Drogasil SA Cash Flow Positive?

  • What Is RADLY Cash Flow From Operations?
    Cash flow from operations (TTM) is $192.8M
  • What Is Raia Drogasil SA’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $64.8M
  • What Is Raia Drogasil SA’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$261.9M

Raia Drogasil SA Return On Invested Capital

  • Is Management Doing A Good Job?
    RADLY return on invested capital is 12.78%
  • What Is Raia Drogasil SA Return On Assets?
    ROA measures how assets are converting to revenues and is 5.74%
  • What Is RADLY Return On Equity?
    ROE is a measure of profitability and is 18.75%

Raia Drogasil SA Earnings Date & Stock Price

Raia Drogasil SA Competitors

  • Who Are Raia Drogasil SA's Competitors?
    Below is a list of companies who compete with Raia Drogasil SA or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • CEL-SCI Corp (CVM)
    • Hypera SA (HYPMY)
    • IGC Pharma Inc (IGC)
    • NovaBay Pharmaceuticals Inc (NBY)

Raia Drogasil SA Dividend Yield

Raia Drogasil SA Analyst Estimates

YoY Growth Past Surprise
EPS: -6.57% 0%
Revenue: 20.96% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many RADLY shares are owned by institutional investors?
    371.5K RADLY shares are owned by institutional investors
  • How many RADLY shares are owned by insiders?
    0 RADLY shares are owned by insiders